| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.4 | 0.004 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.4 | 0.004 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.39 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.38 | 0.002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.31 | 3e-09 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.3 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.27 | 0.2 |